549 related articles for article (PubMed ID: 28856946)
1. Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
Poudel DR; Ghimire S; Dhital R; Forman DA; Warkentin TE
Platelets; 2017 Sep; 28(6):614-620. PubMed ID: 28856946
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies.
Okata T; Miyata S; Miyashita F; Maeda T; Toyoda K
Platelets; 2015; 26(6):602-7. PubMed ID: 25383922
[TBL] [Abstract][Full Text] [Related]
5. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
Manji F; Warkentin TE; Sheppard JI; Lee A
Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
[TBL] [Abstract][Full Text] [Related]
6. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
Warkentin TE; Cook RJ; Marder VJ; Sheppard JA; Moore JC; Eriksson BI; Greinacher A; Kelton JG
Blood; 2005 Dec; 106(12):3791-6. PubMed ID: 16109780
[TBL] [Abstract][Full Text] [Related]
7. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune heparin-induced thrombocytopenia.
Greinacher A; Selleng K; Warkentin TE
J Thromb Haemost; 2017 Nov; 15(11):2099-2114. PubMed ID: 28846826
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
Walenga JM; Prechel M; Jeske WP; Hoppensteadt D; Maddineni J; Iqbal O; Messmore HL; Bakhos M
Br J Haematol; 2008 Oct; 143(1):92-9. PubMed ID: 18671707
[TBL] [Abstract][Full Text] [Related]
12. A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement.
Mallik A; Carlson KB; DeSancho MT
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):73-5. PubMed ID: 21076280
[TBL] [Abstract][Full Text] [Related]
13. Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature.
Ezekwudo DE; Chacko R; Gbadamosi B; Batool S; Gaikazian S; Warkentin TE; Sheppard JI; Jaiyesimi I
Exp Hematol Oncol; 2017; 6():21. PubMed ID: 28725494
[TBL] [Abstract][Full Text] [Related]
14. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia.
Warkentin TE
Thromb Haemost; 2016 Oct; 116(5):813-822. PubMed ID: 27656712
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
Ortel TL
Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin-induced thrombocytopenia in a child.
Dager WE; White RH
Ann Pharmacother; 2004 Feb; 38(2):247-50. PubMed ID: 14742760
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Warkentin TE; Greinacher A
Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477
[TBL] [Abstract][Full Text] [Related]
18. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
[TBL] [Abstract][Full Text] [Related]
19. [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation].
Mahlfeld K; Franke J; Schaeper O; Kayser R; Grasshoff H
Unfallchirurg; 2002 Apr; 105(4):327-31. PubMed ID: 12066471
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.
Fabris F; Luzzatto G; Soini B; Ramon R; Scandellari R; Randi ML; Girolami A
J Intern Med; 2002 Aug; 252(2):149-54. PubMed ID: 12190890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
